Drug Trial Radar · NCT01132326
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
Last checked: Nov 20, 2026Latest source record: Feb 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
350
Actual
Start
Jan 2009
Primary completion
Feb 2013
Study completion Feb 2013
Sponsor
- Lead sponsor
- Chelsea TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- May 28, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Symptomatic NOH in patients with primary autonomic failure is thought to be a consequence of norepinephrine depletion leading to a diminished capacity to effect an appropriate cardiovascular response to an orthostatic challenge resulting in symptomatic cerebral-hypoperfusion. Droxidopa augments norepinephrine levels which should lead to improved cerebral perfusion following orthostatic challenge thereby reducing the symptoms of NOH. The present study will evaluate the long-term safety of droxidopa.
Conditions
- Primary Autonomic Failure
- Dopamine Beta Hydroxylase Deficiency
- Non-Diabetic Neuropathy
- Neurogenic Orthostatic Hypotension
Interventions
DroxidopaDrug
Oral, 100, 200, 300, 400, 500, 600 mg TID, 12 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patients With Treatment-emergent Adverse EventsTime frame: up to 2 years
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.